|
Innovative work in genetic testing is apparently spelled Innogenetics in any language. The biopharmaceutical company creates genetic, infectious disease, cancer, and neurological tests. Innogenetics' products include tests and genotyping profiles to identify conditions such as cystic fibrosis, HIV, hepatitis C and B, Alzheimer's disease, and human papillomavirus (HPV). In addition to testing, the company provides biological manufacturing services (producing virus strains and proteins) for pharmaceutical firms and research labs. The firm's products are sold through subsidiaries and distributors in about 90 countries. Belgium's Solvay took over control of Innogenetics in 2008.
|
| | | Contact Information | |
Address: |
Technologiepark 6
9052 Gent, Belgium
| | Phone: | +32-9-329-13-29 | | Fax: | +32-9-329-19-11 |
|
| Financial
Highlights | | Fiscal Year End: | December |
|
|
Key People
| | • |
CEO:
Christiaan De Wilde
|
|
|
